Jeannie Hou
- Dermatology top 0.5%
- Cancer and Skin Lesions 9
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- Cancer-related Molecular Pathways 4
- Epidemiology top 5%
- Nonmelanoma Skin Cancer Studies 8
- Hepatology top 5%
- Molecular Biology top 10%
- Hedgehog Signaling Pathway Studies 14
- Melanoma and MAPK Pathways 4
-
- Computational Drug Discovery Methods 3
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Daniel I. H. LinzerS. Nicholas AgoffBarbara WuAleksandar SekulićAxel HauschildNicole Basset‐SéguinDirk SchadendorfMichael R. Migden
- Cited by
- DermatologyOncologyEpidemiology
- Journals
- Journal of Clinical Oncology (13 papers)Journal of the American Academy of Dermatology (3 papers)Cancer Research (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Jeannie Hou
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Dermatology 512
- Oncology 642
- Epidemiology 620
- Hepatology 129
- Molecular Biology 935
Countries citing papers authored by Jeannie Hou
This map shows the geographic impact of Jeannie Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeannie Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeannie Hou more than expected).
Fields of papers citing papers by Jeannie Hou
This network shows the impact of papers produced by Jeannie Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeannie Hou. The network helps show where Jeannie Hou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeannie Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 2 | |
| 3 | 2019 | 1 | |
| 4 | 2019 | 2 | |
| 5 | 2019 | 119 | |
| 6 | 2018 | 3 | |
| 7 | 2017 | 3 | |
| 8 | 2017 | 283 | |
| 9 | 2017 | 52 | |
| 10 | 2016 | 2 | |
| 11 | 2015 | 154 | |
| 12 | 2015 | 22 | |
| 13 | 2015 | 56 | |
| 14 | 2014 | 139 | |
| 15 | 2014 | 9 | |
| 16 | 2011 | 2 | |
| 17 | Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with V600E BRAF-mutated melanoma | 2011 | 13 |
| 18 | 2007 | 28 | |
| 19 | 2002 | 12 | |
| 20 | 2000 | 32 |
About Jeannie Hou
Jeannie Hou is a scholar working on Dermatology, Oncology and Molecular Biology, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (14 papers), Cancer and Skin Lesions (9 papers), Nonmelanoma Skin Cancer Studies (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Melanoma and MAPK Pathways (4 papers), Cancer-related Molecular Pathways (4 papers), Computational Drug Discovery Methods (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Dermatology (512 citations), Oncology (642 citations) and Epidemiology (620 citations). Jeannie Hou has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Daniel I. H. Linzer, S. Nicholas Agoff, Barbara Wu, Aleksandar Sekulić, Axel Hauschild, Nicole Basset‐Séguin, Dirk Schadendorf, Michael R. Migden, Karl D. Lewis and Huibin Yue. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Academy of Dermatology, Cancer Research, Annals of Oncology and European Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.